#Rethink your HCP strategy
Monitor HCP clearance for expression systems without access to an ELISA
Now you can rethink your HCP assay strategy with mass spectrometry (MS)-based HCP analysis available from a GMP-certified lab. It is ideal when there is no sufficient generic ELISA for your cell line – or when the time to develop a process-specific ELISA is limited, e.g., for phase 2 and 3 clinical trials.
An MS-based assay has very high HCP coverage and sensitivity and is customizable within weeks. It even enables the identification and quantification of individual HCPs – for instance, across batches for easy comparison of purification strategies. The assay is available for full validation following ICH guidelines and is thus accessible for release testing and commercial production.
Attend this 30-minute live webinar to
- Learn how GMP-accredited HCP analysis using mass spectrometry may change your HCP characterization strategy
- Get an introduction to MS-based HCP analysis, methodology, considerations, and advantages.
- See customer case studies on applying mass spectrometry for HCP purification optimization on E. coli and HEK293 expression systems.